Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCardiovascular

COMT-Catalyzed Palmitic Acid Methyl Ester Biosynthesis in Perivascular Adipose Tissue and its Potential Role Against Hypertension

Chin-Hung Liu, Hao-Jen Hsu, Tzu-Ling Tseng, Tsung-Jen Lin, Wei-Hsiang Weng, Mei-Fang Chen and Tony Jer-Fu Lee
Journal of Pharmacology and Experimental Therapeutics May 2020, 373 (2) 175-183; DOI: https://doi.org/10.1124/jpet.119.263517
Chin-Hung Liu
Department of Pharmacology, College of Medicine (C.-H.L., T.-J.L.), Department of Life Sciences, College of Medicine (H.-J.H., W.-H.W.), and Ph.D program in Pharmacology and Toxicology, Department of Medicine, School of Medicine (C.-H.L., T.-J.L.), Tzu Chi University, Hualien, Taiwan; Department of Medical Research (T.-L.T., M.-F.C., T.J.-F.L.) and Cardiovascular Research Center (C.-H.L., T.-L.T., M.-F.C., T.J.-F.L.), Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; and Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (T.J.-F.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chin-Hung Liu
Hao-Jen Hsu
Department of Pharmacology, College of Medicine (C.-H.L., T.-J.L.), Department of Life Sciences, College of Medicine (H.-J.H., W.-H.W.), and Ph.D program in Pharmacology and Toxicology, Department of Medicine, School of Medicine (C.-H.L., T.-J.L.), Tzu Chi University, Hualien, Taiwan; Department of Medical Research (T.-L.T., M.-F.C., T.J.-F.L.) and Cardiovascular Research Center (C.-H.L., T.-L.T., M.-F.C., T.J.-F.L.), Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; and Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (T.J.-F.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tzu-Ling Tseng
Department of Pharmacology, College of Medicine (C.-H.L., T.-J.L.), Department of Life Sciences, College of Medicine (H.-J.H., W.-H.W.), and Ph.D program in Pharmacology and Toxicology, Department of Medicine, School of Medicine (C.-H.L., T.-J.L.), Tzu Chi University, Hualien, Taiwan; Department of Medical Research (T.-L.T., M.-F.C., T.J.-F.L.) and Cardiovascular Research Center (C.-H.L., T.-L.T., M.-F.C., T.J.-F.L.), Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; and Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (T.J.-F.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsung-Jen Lin
Department of Pharmacology, College of Medicine (C.-H.L., T.-J.L.), Department of Life Sciences, College of Medicine (H.-J.H., W.-H.W.), and Ph.D program in Pharmacology and Toxicology, Department of Medicine, School of Medicine (C.-H.L., T.-J.L.), Tzu Chi University, Hualien, Taiwan; Department of Medical Research (T.-L.T., M.-F.C., T.J.-F.L.) and Cardiovascular Research Center (C.-H.L., T.-L.T., M.-F.C., T.J.-F.L.), Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; and Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (T.J.-F.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei-Hsiang Weng
Department of Pharmacology, College of Medicine (C.-H.L., T.-J.L.), Department of Life Sciences, College of Medicine (H.-J.H., W.-H.W.), and Ph.D program in Pharmacology and Toxicology, Department of Medicine, School of Medicine (C.-H.L., T.-J.L.), Tzu Chi University, Hualien, Taiwan; Department of Medical Research (T.-L.T., M.-F.C., T.J.-F.L.) and Cardiovascular Research Center (C.-H.L., T.-L.T., M.-F.C., T.J.-F.L.), Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; and Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (T.J.-F.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mei-Fang Chen
Department of Pharmacology, College of Medicine (C.-H.L., T.-J.L.), Department of Life Sciences, College of Medicine (H.-J.H., W.-H.W.), and Ph.D program in Pharmacology and Toxicology, Department of Medicine, School of Medicine (C.-H.L., T.-J.L.), Tzu Chi University, Hualien, Taiwan; Department of Medical Research (T.-L.T., M.-F.C., T.J.-F.L.) and Cardiovascular Research Center (C.-H.L., T.-L.T., M.-F.C., T.J.-F.L.), Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; and Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (T.J.-F.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tony Jer-Fu Lee
Department of Pharmacology, College of Medicine (C.-H.L., T.-J.L.), Department of Life Sciences, College of Medicine (H.-J.H., W.-H.W.), and Ph.D program in Pharmacology and Toxicology, Department of Medicine, School of Medicine (C.-H.L., T.-J.L.), Tzu Chi University, Hualien, Taiwan; Department of Medical Research (T.-L.T., M.-F.C., T.J.-F.L.) and Cardiovascular Research Center (C.-H.L., T.-L.T., M.-F.C., T.J.-F.L.), Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan; and Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (T.J.-F.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

Decreased release of palmitic acid methyl ester (PAME), a vasodilator, from perivascular adipose tissue (PVAT) might contribute to hypertension pathogenesis. However, the PAME biosynthetic pathway remains unclear. In this study, we hypothesized that PAME is biosynthesized from palmitic acid (PA) via human catechol-O-methyltransferase (COMT) catalysis and that decreased PAME biosynthesis plays a role in hypertension pathogenesis. We compared PAME biosynthesis between age-matched normotensive Wistar Kyoto (WKY) rats and hypertensive spontaneously hypertensive rats (SHRs) and investigated the effects of losartan treatment on PAME biosynthesis. Computational molecular modeling indicated that PA binds well at the active site of COMT. Furthermore, in in vitro enzymatic assays in the presence of COMT and S-5′-adenosyl-L-methionine (AdoMet), the stable isotope [13C16]-PA was methylated to form [13C16]-PAME in incubation medium or the Krebs–Henseleit solution containing 3T3-L1 adipocytes or rat PVAT. The adipocytes and PVATs expressed membrane-bound (MB)-COMT and soluble (S)-COMT proteins. [13C16]-PA methylation to form [13C16]-PAME in 3T3-L1 adipocytes and rat PVAT was blocked by various COMT inhibitors, such as S-(5′-adenosyl)-L-homocysteine, adenosine-2′,3′-dialdehyde, and tolcapone. MB- and S-COMT levels in PVATs of established SHRs were significantly lower than those in PVATs of age-matched normotensive WKY rats, with decreased [13C16]-PA methylation to form [13C16]-PAME. This decrease was reversed by losartan, an angiotensin II (Ang II) type 1 receptor antagonist. Therefore, PAME biosynthesis in rat PVAT is dependent on AdoMet, catalyzed by COMT, and decreased in SHRs, further supporting the role of PVAT/PAME in hypertension pathogenesis. Moreover, the antihypertensive effect of losartan might be due partly to its increased PAME biosynthesis.

SIGNIFICANCE STATEMENT PAME is a key PVAT-derived relaxing factor. We for the first time demonstrate that PAME is synthesized through PA methylation via the S-5′-adenosyl-L-methionine–dependent COMT catalyzation pathway. Moreover, we confirmed PVAT dysfunction in the hypertensive state. COMT-dependent PAME biosynthesis is involved in Ang II receptor type 1–mediated blood pressure regulation, as evidenced by the reversal of decreased PAME biosynthesis in PVAT by losartan in hypertensive rats. This finding might help in developing novel therapeutic or preventive strategies against hypertension.

Footnotes

    • Received October 31, 2019.
    • Accepted February 10, 2020.
  • ↵1 M.-F.C. and T.J.-F.L. contributed equally to this work.

  • Tony Jer-Fu Lee died on February 15th, 2018.

  • This work was supported by grants from Tzu Chi Medical Foundation [TCMMP104-01-04], National Health Research Institutes [NHRI-EX104-10232SI], and the Ministry of Science and Technology [MOST105-2320-B-303-001-MY3 and MOST106-2320-B-320-011-] of Taiwan.

  • https://doi.org/10.1124/jpet.119.263517.

  • ↵Embedded ImageThis article has supplemental material available at jpet.aspetjournals.org.

  • Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 373 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 373, Issue 2
1 May 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
COMT-Catalyzed Palmitic Acid Methyl Ester Biosynthesis in Perivascular Adipose Tissue and its Potential Role Against Hypertension
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCardiovascular

COMT-Mediated PAME Biosynthesis

Chin-Hung Liu, Hao-Jen Hsu, Tzu-Ling Tseng, Tsung-Jen Lin, Wei-Hsiang Weng, Mei-Fang Chen and Tony Jer-Fu Lee
Journal of Pharmacology and Experimental Therapeutics May 1, 2020, 373 (2) 175-183; DOI: https://doi.org/10.1124/jpet.119.263517

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCardiovascular

COMT-Mediated PAME Biosynthesis

Chin-Hung Liu, Hao-Jen Hsu, Tzu-Ling Tseng, Tsung-Jen Lin, Wei-Hsiang Weng, Mei-Fang Chen and Tony Jer-Fu Lee
Journal of Pharmacology and Experimental Therapeutics May 1, 2020, 373 (2) 175-183; DOI: https://doi.org/10.1124/jpet.119.263517
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • 4-Chloro ring-substituted synthetic cathinones
  • 14-3-3 Influences Nav1.5 Response to Anti-Arrhythmic Drugs
  • Inhaled Treprostinil Palmitil in the Sugen/Hypoxia Rat Model
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics